Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart
  • Log out

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Effectiveness of exercise training in patients with COPD: the role of muscle fatigue

Chris Burtin, Didier Saey, Melda Saglam, Daniel Langer, Rik Gosselink, Wim Janssens, Marc Decramer, François Maltais, Thierry Troosters
European Respiratory Journal 2012 40: 338-344; DOI: 10.1183/09031936.00111811
Chris Burtin
*Faculty of Kinesiology and Rehabilitation Sciences, Dept of Rehabilitation Sciences, Katholieke Universiteit Leuven
#Respiratory Rehabilitation and Respiratory Division, University Hospitals KULeuven, Leuven, Belgium
+These authors contributed equally to the manuscript
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Didier Saey
¶Centre de recherche de l' Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université, Laval, Quebec, QC, Canada
+These authors contributed equally to the manuscript
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Melda Saglam
#Respiratory Rehabilitation and Respiratory Division, University Hospitals KULeuven, Leuven, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Langer
*Faculty of Kinesiology and Rehabilitation Sciences, Dept of Rehabilitation Sciences, Katholieke Universiteit Leuven
#Respiratory Rehabilitation and Respiratory Division, University Hospitals KULeuven, Leuven, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rik Gosselink
*Faculty of Kinesiology and Rehabilitation Sciences, Dept of Rehabilitation Sciences, Katholieke Universiteit Leuven
#Respiratory Rehabilitation and Respiratory Division, University Hospitals KULeuven, Leuven, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wim Janssens
#Respiratory Rehabilitation and Respiratory Division, University Hospitals KULeuven, Leuven, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc Decramer
#Respiratory Rehabilitation and Respiratory Division, University Hospitals KULeuven, Leuven, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
François Maltais
¶Centre de recherche de l' Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université, Laval, Quebec, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thierry Troosters
*Faculty of Kinesiology and Rehabilitation Sciences, Dept of Rehabilitation Sciences, Katholieke Universiteit Leuven
#Respiratory Rehabilitation and Respiratory Division, University Hospitals KULeuven, Leuven, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: thierry.troosters@med.kuleuven.be
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

The improvement in exercise performance in response to exercise training varies greatly from one patient with chronic obstructive pulmonary disease to another. It is possible that in a portion of patients the muscle stimulus applied during exercise training is insufficient to elicit training effects. We investigated whether patients presenting quadriceps contractile fatigue after training have more favourable effects of a rehabilitation programme.

46 patients followed a 3-month high-intensity exercise training programme. Exercise capacity, quadriceps force and quality of life were measured before and after the programme. Exercise training-induced quadriceps contractile fatigue was assessed after 1 month of rehabilitation with magnetic stimulation. A fall in quadriceps force of ≥15%, 15 min after training was considered as significant fatigue.

29 (63%) out of 46 patients developed significant fatigue. Patients with fatigue had a higher increase in 6-min walk distance (median (interquartile range) 57 (47–103) m versus 17 (-7–46) m; p=0.0023) and Chronic Respiratory Disease Questionnaire score (mean±sd 22±12 points versus 14±12 points; p=0.028) after the training programme compared with patients without fatigue. Improvements in quadriceps force and maximal exercise capacity were similar in both subgroups.

Patients who develop quadriceps contractile fatigue during exercise training show greater training effects in terms of functional exercise capacity and health-related quality of life.

  • Exercise therapy
  • exercise tolerance
  • muscle
  • quality of life
  • rehabilitation
  • skeletal

Pulmonary rehabilitation is an essential nonpharmacologic treatment option for patients with chronic obstructive pulmonary disease (COPD) [1, 2]. Comprehensive pulmonary rehabilitation reduces dyspnoea, increases exercise tolerance, improves health-related quality of life and reduces the use of healthcare resources [3, 4]. Although pulmonary rehabilitation is a multidisciplinary treatment, exercise training forms the basis of its effects [3].

In some patients with COPD, exercise tolerance improves to a lesser extent after an exercise training programme [5]. In general, patients with muscle weakness and low baseline exercise tolerance who show less ventilatory limitation experience greater improvements in their exercise capacity [5–7]. Only a limited amount of the variability in training response can be explained with these variables, leaving room for other potential predictors of the success of exercise training.

Skeletal muscle overload is an important training principle indicating that the level of the training load has to be sufficient to stress the muscle in order to obtain physiological training adaptations [8–10]. We speculated that the onset of contractile muscle fatigue during exercise is a marker of muscle overload. A proportion of patients do not develop contractile fatigue of the quadriceps after whole-body [11, 12] or single muscle [13] endurance exercise performed up to exhaustion. It is currently unknown whether contractile fatigue occurs during exercise training, which typically consists of several submaximal episodes of exercise. In the absence of muscle overload, training effects could be less pronounced.

In the present study we hypothesised that the occurrence of contractile fatigue of the quadriceps after a training session in patients with COPD would be associated with a more favourable outcome after an exercise training programme. As a result, the presence of contractile fatigue after a training session would be a marker of skeletal muscle overload during training.

We addressed this hypothesis through a multicentre cohort study conducted in Leuven (Belgium) and Quebec (Canada). Some of the results of this study have been previously reported in abstract form [14].

METHODS

Subjects

A convenience sample of 57 patients that were referred for outpatient pulmonary rehabilitation at University Hospital Gasthuisberg, Leuven (n=49) and at Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec (n=8) were enrolled in the study. All patients had a primary diagnosis of COPD [15]. Exclusion criteria were diagnosis of cancer, significant cardiac disease, cerebral, neurological or neuromuscular disorders and severe arthrosis, arthritis or other musculoskeletal limitations that impaired the testing procedures or exercise training. Since magnetic stimulation of the femoral nerve was conducted, patients with right hip arthroplasty or arterial bypass surgery in the pelvic or abdominal region were excluded.

Written informed consent was obtained from all patients. The study protocol was approved by the ethics committee of both hospitals.

Study design

All patients followed a 3-month multidisciplinary pulmonary rehabilitation programme, including three weekly exercise training sessions. Before and after the training programme, patients underwent an evaluation of lung function, respiratory and peripheral muscle force, maximal exercise capacity, 6-min walk distance (6MWD) and health-related quality of life (Chronic Respiratory Disease Questionnaire; CRDQ). The clinical staff who conducted these evaluations were blinded to the outcome of the fatigue measurement. Using magnetic stimulation, maximum voluntary contraction (MVC) and potentiated quadriceps twitch force (TWqpot) were assessed after 1 week and 1 and 3 months of rehabilitation. Muscle assessments were performed before and 15 and 40 min after the exercise training session. A fall in TWqpot of >15% 15 min after exercise training was defined as significant contractile fatigue [11]. The degree of quadriceps contractile fatigue induced by a single training session was reported after 1 month of rehabilitation, when patients were fully familiarised with the training programme. Both centres used the same equipment for all testing procedures.

Assessment of quadriceps strength

The right quadriceps force was evaluated using MVC and transcutaneous magnetic twitch stimulation of the femoral nerve. Subjects were sitting in a recumbent chair with hips extended at 120°, knees flexed at 90° and arms crossed in front of the chest. The following measures were performed in a fixed order to obtain a comprehensive assessment of skeletal muscle force.

Unpotentiated quadriceps twitch contraction

At rest, the femoral nerve was stimulated through a 45-mm, figure-of-eight coil powered by a double Magstim stimulator (Magstim Co Ltd, Whitland, UK). The strain-gauge signal was transformed by an analogue force transducer (546QD; CDS Europe, Milan, Italy), amplified (Biopac mp150; Biopac Systems, Goleta, CA, USA) and stored on a computer. Twitch forces were measured at 30, 50, 70, 80, 90, 95 and 100% of the maximum stimulator output to ensure supramaximality of the measurement.

Maximal voluntary contraction

Subjects performed five isometric MVC for 3 s.

Potentiated quadriceps twitch contraction

TWqpot was systematically measured 3 s after the end of each MVC manoeuvre. The femoral nerve was stimulated with a twitch at 100% of power output of the stimulator. For analysis, the mean of the two highest values was calculated. Superimposed twitches were obtained during the preceding MVC to ensure maximal potentiation. The mean size of this superimposed twitch was 1.2±4.3 N (median 0 N) or 0.5±2% of the MVC (median 0%), suggesting a truly reliable maximum effort during MVC in strongly encouraged patients.

Measurements pre- and post-rehabilitation programme

Static and dynamic lung volumes were measured according to the European Respiratory Society guidelines [16, 17]. Diffusing capacity of the lung was assessed by the single breath method [18]. Maximal isometric voluntary contraction force of the quadriceps was measured as described previously. Maximal inspiratory pressure was measured from residual volume (MicroRPM; CareFusion, Basingstoke, UK) and was compared with reference values [19]. Functional exercise capacity was assessed using the 6MWD test. The best of two standardised tests was reported as percentage of the predicted value [20]. Maximal exercise capacity was evaluated using an incremental cycle ergometer (Ergometrics 900; Ergoline, Bitz, Germany). After 2 min of resting breathing, patients started a 3-min unloaded warm-up period. Subsequently work rate was increased by 10 W·min−1 until the symptom limited peak work rate was reached [21]. Oxygen uptake (V′O2), carbon dioxide production (V′CO2) and ventilation were measured breath-by-breath and averaged over 30 s (Vmax series; SensorMedics, Anaheim, CA, USA). Maximal voluntary ventilation was measured over 12 s.

The CRDQ was used to assess health-related quality of life [22]. This 20-item questionnaire scores quality of life in four domains (dyspnoea, mastery, emotional functioning and fatigue) and has been validated in the Dutch language [23]. The total score can range from 20 to 140 with higher scores indicating better quality of life.

Exercise training

Exercise training included treadmill walking, quadriceps resistance exercise, stair climbing and cycling. The initial workload during walking was set at 75% of the mean walking speed during the 6MWD test. The initial workload during cycling was set at 60–70% of the maximal workload (Wmax) during the symptom-limited incremental cycle test. The target duration of cycling and walking increased from 10 min at week 2 to 16 min at week 12. The standard exercise modality was endurance training, but interval training (2 min episodes of exercise alternated with 1-min resting periods) was used if necessary to provide the desired training intensity. Stair climbing consisted of climbing two steps up and two steps down at the patient's own pace. Resistance training on a leg press apparatus consisted of three series of eight repetitions, with an initial load of 70% of the one-repetition maximum. The training intensity was gradually increased over time, using a Borg scale rating of four to six on perceived exertion or dyspnoea as an indicator of adequate training intensity. Every training session was supervised by experienced and blinded physiotherapists who ensured an adequate training intensity. The sequence of the different exercises was standardised during the training session at which contractile fatigue was measured (i.e. walking, resistance exercise, stair climbing and cycling). Oxygen therapy was permitted during training to keep oxygen saturation >90%. Patients attended 32±5 training sessions (adherence of 80±11%).

Statistical analysis

All statistical analyses were performed with SAS 9.1.3 (SAS Institute Inc., Cary, NC, USA). Data are expressed as mean±sd or median (interquartile range). The level of significance was 0.05 for all statistical tests. Between-group differences were evaluated using unpaired t-tests or Wilcoxon Mann–Whitney tests. Repeated measures were analysed using paired t-tests, Wilcoxon signed-rank tests or repeated-measures of ANOVA. Chi-squared tests and odds ratios (95% confidence interval) were used to compare proportions. Pearson or Spearman rank correlation coefficients were used to evaluate relationships between variables. An exponential function, V′CO2=b×(exp (k×V′O2) + a, was constructed to describe the relationship between V′CO2 and V′O2 during the maximal exercise tests before and after the training programme. The change in V′CO2 at iso-V′O2 (maximal V′O2 obtained in both tests) after the training programme was computed using this formula.

RESULTS

Patient flow

57 eligible patients agreed to participate in the study. Eight patients dropped out from rehabilitation because of lung transplantation (n=3) or serious respiratory (n=3) or cardiac (n=2) complications. Two patients withdrew their informed consent and one did not perform the muscle force protocol after 1 month because of a calcaneus fracture, leaving 46 patients for the final analysis. One patient did not perform the 6MWD test after 3 months and CRDQ score was not reliably assessed in two patients due to poor understanding of the questionnaire. Baseline characteristics are reported in table 1. No baseline differences were found between drop-outs and patients that completed the training programme.

View this table:
  • View inline
  • View popup
Table 1– Baseline characteristics of study participants

Contractile fatigue of the quadriceps after exercise

Compared to resting values, 15 and 40 min after the end of the training session TWqpot decreased by 19±12% and 20±9%, respectively (both p<0.05). Figure 1 shows that various levels of fatigue were observed. 29 (63%) out of 46 patients developed significant contractile fatigue (>15% decrease in TWqpot) 15 min after training. Patients with fatigue also had a more pronounced decrease in TWqpot (-24±11% versus -7±8%; p<0.0001) and MVC (-8±8% versus -1±7%; p=0.002) after training compared to patients without fatigue. The development of fatigue was consistent throughout the rehabilitation programme (weeks 1, 5 and 12). Patients with contractile fatigue had more baseline static hyperinflation compared to those who did not develop contractile fatigue (total lung capacity 125±16% pred versus 106±16% pred (p<0.001), respectively; functional residual capacity 175±36% pred versus 145±29% pred (p<0.01), respectively) (table 1). No baseline differences in spirometry data, diffusion capacity, anthropometric measures, muscle force, exercise capacity or quality of life were detected between patients with and without contractile fatigue (table 1). The training workload (intensity and duration) at weeks 2, 5 and 12 of the training programme was not different between groups. Figure 2 shows that training intensities were similar between the two groups at these time-points. Treadmill speed increased from 74±15% (week 2) to 109±29% (week 12) of the initial speed during the initial 6MWD test. Cycling workload increased from 70±12% (week 2) to 97±26% (week 12) of the Wmax during the initial incremental cycle test. The workload of the quadriceps resistance exercise increased from 71±10% (week 2) to 94±30% (week 12) of the initial one-repetition maximum. Duration of the different training modalities was also comparable between groups. Dyspnoea and fatigue Borg scores at the end of the cycling training were also similar (dyspnoea 4±1 versus 4±1 (p=0.83) and fatigue 4±1 versus 4±1 (p=0.33) in patients with and without fatigue, respectively). When taking into account the highest of both symptom scores in each patient, mean symptom score at the end of cycling training was 5±2 in patients with fatigue and 5±1 in patients without fatigue. 17 (65%) out of 29 patients with fatigue trained with oxygen supplements compared with 11 (59%) out of 17 patients without fatigue (p=0.68). Adherence to training was also similar in patients with and without fatigue (30±5 versus 28±6 attended sessions, p=0.56).

Figure 1–
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1–

Individual changes in quadriceps potentiated twitch force (TWqpot) 15- and 40-min post-exercise training. 15 min after training, 29 (69%) out of 46 patients showed a >15% decrease in force (- - - -).

Figure 2–
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2–

Training intensity at weeks (w) 2, 5 and 12 during the 3-month training programme in patients with and without quadriceps contractile fatigue. Cycling intensity is expressed as % of maximal workload during the baseline incremental cycle test, walking intensity as % of the speed during the baseline 6-min walk test, and leg extension as % of the one-repetition maximum, assessed during the first training session.

Training effects

After 3 months of exercise training, the whole patient group showed a significant increase in 6MWD (50 (19–85) m, p<0.0001), maximal exercise capacity (Wmax 10 (1–20) W, p<0.0001; maximal V′O2(V′O2,max) 113 (-50–259) mL·min−1, p=0.0002), isometric quadriceps force (20 (-6–5) N, p=0.03) and CRDQ score (19±12 points, p<0.0001).

Contractile fatigue and training effects

The increase in 6MWD was significantly larger in the patients who developed fatigue compared to those who did not (57 (47–103) versus 17 (-7–46) m, p=0.0023) (fig. 3a). 71% of patients with fatigue showed an improvement in 6MWD exceeding the proposed clinically important difference of 50 m [24], compared with 18% of patients without fatigue (OR 11.7 (95% CI 2.6–51.9), p=0.0005). Symptoms of dyspnoea and leg fatigue during the 6MWD test did not change from baseline and were similar in the two groups. Similarly the CRDQ score improved significantly more in the patients with fatigue (22±12 versus 14±12 points, p=0.028). This difference was mainly reflected in the dyspnoea subdomain (7.3±4.2 versus 3.9±5.9 points, p<0.031) (fig. 3b), whereas in the fatigue (4.4±3.4 versus 2.9±3.3, p=0.15), mastery (4.5±3.6 versus 3.3±3.5, p=0.31) or emotional functioning (5.8±4.5 versus 4.2±3.5, p=0.21) subdomains no significant difference was found between subgroups. 86% of patients with contractile fatigue showed an increase exceeding the proposed clinically important difference (2.5 points) [25] in the dyspnoea score compared with 56% of patients without fatigue (OR 4.7 (95% CI 1.1–19.9), p=0.03). Despite the significant improvement induced by training for the whole group, the increase in quadriceps force (24 (-6–35) N versus 12 (-6–34) N, p=0.70) (fig. 3c) or maximal exercise capacity (Wmax 10 (1–19) W versus 10 (2–20) W, p=0.94; V′O2,max 112 (-73–248) versus 126 (23–259) mL·min−1, p=0.79) (fig. 3d) were not statistically different between patients with or without fatigue. Symptoms of dyspnoea and leg fatigue during incremental cycling did not change from baseline and were similar in the two groups. The correlation between decrease in TWqpot after exercise training and decrease in V′CO2 at iso-VO2 (baseline V′O2,max) after 3 months was 0.35 (p=0.05).

Figure 3–
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3–

Individual change (Δ) in a) 6-min walk distance (6MWD), b) Chronic Respiratory Disease Questionnaire (CRDQ) dyspnoea score, c) quadriceps force, and d) maximal workload (Wmax) during incremental exercise testing after the training programme in patients with and without quadriceps contractile fatigue. ––––: median score of each group; - - - -: estimated clinical important difference for this variable. ns: nonsignificant.*: p<0.05 between groups.

DISCUSSION

The present study indicates that patients who develop significant quadriceps contractile fatigue during an exercise training session have favourable training response in terms of functional exercise capacity and health-related quality of life compared to those who do not. An appreciably higher fraction of patients with contractile fatigue after training showed a clinically relevant increase in 6MWD and a decrease in symptoms of dyspnoea during activities of daily living compared with patients who did not develop fatigue. Furthermore, a greater reduction in V′CO2 at iso-V′O2, an effort-independent marker of improvement, was seen in patients with more pronounced contractile fatigue. Based on these findings, we report that contractile fatigue of the quadriceps is a probable marker of overload to the skeletal muscle. However, we could not identify simple clinical characteristics that could help predict the development of quadriceps fatigue. In addition the training intensity was high and not significantly different in both groups.

Contractile fatigue after exercise

The quadriceps muscle is more susceptible to develop early contractile fatigue in patients with moderate-to-severe COPD compared with healthy age-matched controls [12, 13]. The majority of patients with COPD develop quadriceps contractile fatigue during an endurance cycle test performed until symptom limitation [11, 12] or several episodes of maximal single muscle exercise [13]. This is in line with our findings that 60% of patients develop quadriceps contractile fatigue during an exercise training session consisting of several episodes of submaximal exercise.

Patients with and without contractile fatigue after training

It is unclear why some patients do not develop contractile fatigue during training. One assumption would be that patients with a chronic lung disease who do not develop muscle fatigue during exercise do not achieve an adequate training intensity due to ventilatory constraints. Our findings do not confirm this hypothesis. The sensation of breathlessness during exercise was not related to the development of contractile fatigue during training. During maximal incremental cycle exercise the two subgroups of patients clearly reached their ventilatory limits at a comparable work rate. We did not perform measurements of inspiratory capacity during exercise to investigate the development of dynamic hyperinflation during exercise. However, in the absence of differences in transfer factor of the lung for carbon monoxide [26] and given the fact that more static hyperinflation was found in patients with contractile fatigue, it is unlikely that this group would have had less dynamic hyperinflation. Based on this information we have no evidence to assume a different ventilatory constraint during exercise training between groups.

Interestingly, the absolute and relative training load was not different between patients with and without significant contractile fatigue. This leads to the hypothesis that the susceptibility to develop contractile fatigue would be driven by muscle characteristics rather than the performed work.

The susceptibility to develop contractile fatigue during exercise is seen more often in patients with higher glycolytic enzyme activity in the muscle cytoplasm, lower muscle capillarisation and earlier blood lactate accumulation during exercise [27]. In these patients intrinsic muscle changes associated with early metabolite accumulation during exercise training may lead to early contractile failure of the working muscles, despite the low absolute exercise intensities [28]. Ventilatory limitations might prevent patients with better preserved oxidative metabolism from reaching a sufficient training intensity to induce a similar overload.

Contractile fatigue and training response

The development of contractile fatigue during exercise training was related to the magnitude of improvement in 6MWD and health-related quality of life following the training programme but not to the changes in maximal exercise capacity and isometric quadriceps force. In general, submaximal endurance exercise tests are more responsive to changes in aerobic metabolism than maximal exercise tests [29]. This could explain why changes in 6MWD (a submaximal exercise test) were related to muscle fatigue induced by exercise training while changes in maximal exercise capacity were not. As maximal exercise capacity is closely related to lung function [30], subtle changes in forced expiratory volume in 1 s over time could influence the change in V′O2max after rehabilitation. Looking at an effort-independent measure of the physiological training effect, the decrease in V′CO2 at iso-V′O2 was correlated with the degree of muscle fatigue after exercise training.

No statistical difference was found in maximal isometric quadriceps force increase between patients with and without fatigue, even though the increase tended to be larger in the former group. Changes in maximal isometric muscle force reflect muscular and neuromuscular adaptations to exercise training which seem to be similar in both subgroups. The muscle stimulus that may lead to gains in plain muscle strength may not be adequately assessed by looking at muscle fatigue after training.

Methodological considerations

The multidisciplinary pulmonary rehabilitation programme in both centres was conducted according to international guidelines [1, 31] and improvements of relevant clinical outcomes (6MWD and quality of life) were clinically relevant [24, 25] and consistent with changes seen after similar programmes in the literature [3, 4]. The mean symptom score on the modified Borg scale after cycling exercise (∼5) indicates that patients trained at an adequate intensity [32].

Supramaximal magnetic stimulation of the femoral nerve is an involuntary, well-tolerated and valid technique which is used to assess low-frequency quadriceps contractile fatigue in patients with COPD [12, 33, 34]. The definition of fatigue was based on measurements of TWqpot. A fall in TWqpot of >15% has been used previously to define contractile fatigue [11]. The present study renders some additional validity to this cut-off. We chose to perform the contractile fatigue measurement 1 month after inclusion in an exercise training programme because patients were fully accustomed to the training procedure at the time of the measurement. We acknowledge that muscle fatigue is not an all-or-nothing phenomenon and that some patients who did not exhibit a fall in TWqpot of >15% after the training session may still have developed some degree of fatigue. This could lead to an underestimation of the differences between the two subgroups of patients, both in terms of baseline characteristics and training results. The correlation between the degree of change in V′CO2 at iso-V′O2 would support the idea.

Limitations of the study

First, we did not include a whole-body or local muscle endurance test or a skeletal muscle biopsy due to logistical restrictions. These tests would have provided more straightforward information on improvements in aerobic metabolism compared with an incremental cycle exercise test and a maximal isometric muscle test.

Secondly, we did not measure changes in inspiratory capacity during exercise training or testing. Consequently, we cannot make firm conclusions on the influence of dynamic hyperinflation on the ability to develop muscle fatigue.

Finally, we defined patients with or without muscle fatigue based on the development of fatigue during a single training session after 1 month of rehabilitation. However, when performing the same analysis with fatigue results after 1 week and 3 months of training similar results are found.

Clinical relevance

Our results emphasise the importance of developing fatigue of the quadriceps muscles during exercise training to optimise training effects in patients with moderate-to-severe COPD. Interestingly, a high relative training intensity is no guarantee to provide a significant stimulus to the muscle. It would be interesting to establish whether changes in training strategies (e.g. one-legged training [35]) could stimulate the development of contractile fatigue in patients who do not develop fatigue during the exercise training and whether this leads to improved training results in these patients.

Conclusion

Patients with COPD developing quadriceps contractile fatigue during exercise training showed larger training effects in terms of functional exercise capacity and health-related quality of life compared to those who did not develop fatigue.

Acknowledgments

The authors would like to thank physiotherapists V. Barbier, I. Coosemans and I. Muylaert and the staff of both the Respiratory Rehabilitation Department and the Pulmonary Function Department at the University Hospitals Gasthuisberg (Leuven, Belgium) for providing the exercise training and performing the clinical tests. S. Gielissen, A. Knoops and S. Asselman (all KU Leuven, Leuven) provided assistance with data analysis. The authors also acknowledge the contribution of M. Bélanger, M-J. Breton, B. Jean and J. Picard (all Centre de recherché de l’Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec, QC, Canada) in accomplishing this study and are grateful to T. Gaudet-Savard and C. Girard for providing the exercise testing and the clinical tests at the Institut Universitaire de Cardiologie et de Pneumologie de Québec.

Footnotes

  • Support Statement

    Supported by grant G.0598.09N of the Flemish Research Foundation. C. Burtin is a doctoral fellow of Research Foundation Flanders. D. Saey is a postdoctoral fellow of CIHR and of la Fondation J.D. Bégin de la Chaire de Pneumologie de l’Université Laval. M. Saglam is the recipient of a European Respiratory Society fellowship (no. 343). D. Langer is a postdoctoral fellow of Research Foundation Flanders.

  • Statement of Interest

    A statement of interest for M. Decramer can be found at www.erj.ersjournals.com/site/misc/statements.xhtml

  • Received June 29, 2011.
  • Accepted November 21, 2011.
  • ©ERS 2012

REFERENCES

  1. ↵
    1. Nici L,
    2. Donner C,
    3. Wouters E,
    4. et al
    . American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006; 173: 1390–1413.
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    1. Ries AL,
    2. Bauldoff GS,
    3. Carlin BW,
    4. et al
    . Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest 2007; 131: Suppl. 5, 4S–42S.
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. Troosters T,
    2. Casaburi R,
    3. Gosselink R,
    4. et al
    . Pulmonary rehabilitation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 172: 19–38.
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    1. Lacasse Y,
    2. Goldstein R,
    3. Lasserson TJ,
    4. et al
    . Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006; 4: CD003793.
    OpenUrlPubMed
  5. ↵
    1. Troosters T,
    2. Gosselink R,
    3. Decramer M
    . Exercise training in COPD: how to distinguish responders from nonresponders. J Cardiopulm Rehabil 2001; 21: 10–17.
    OpenUrlCrossRefPubMed
    1. Zu Wallack RL,
    2. Patel K,
    3. Reardon JZ,
    4. et al
    . Predictors of improvement in the 12-minute walking distance following a six-week outpatient pulmonary rehabilitation program. Chest 1991; 99: 805–808.
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    1. Plankeel JF,
    2. McMullen B,
    3. MacIntyre NR
    . Exercise outcomes after pulmonary rehabilitation depend on the initial mechanism of exercise limitation among non-oxygen-dependent COPD patients. Chest 2005; 127: 110–116.
    OpenUrlCrossRefPubMedWeb of Science
  7. ↵
    1. Byrne C,
    2. Twist C,
    3. Eston R
    . Neuromuscular function after exercise-induced muscle damage: theoretical and applied implications. Sports Med 2004; 34: 49–69.
    OpenUrlCrossRefPubMedWeb of Science
    1. Charge SB,
    2. Rudnicki MA
    . Cellular and molecular regulation of muscle regeneration. Physiol Rev 2004; 84: 209–238.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. McNicol AJ,
    2. O'Brien BJ,
    3. Paton CD,
    4. et al
    . The effects of increased absolute training intensity on adaptations to endurance exercise training. J Sci Med Sport 2009; 12: 485–489.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Saey D,
    2. Debigare R,
    3. LeBlanc P,
    4. et al
    . Contractile leg fatigue after cycle exercise: a factor limiting exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 168: 425–430.
    OpenUrlCrossRefPubMedWeb of Science
  10. ↵
    1. Mador MJ,
    2. Bozkanat E,
    3. Kufel TJ
    . Quadriceps fatigue after cycle exercise in patients with COPD compared with healthy control subjects. Chest 2003; 123: 1104–1111.
    OpenUrlCrossRefPubMedWeb of Science
  11. ↵
    1. Mador MJ,
    2. Deniz O,
    3. Aggarwal A,
    4. et al
    . Quadriceps fatigability after single muscle exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 168: 102–108.
    OpenUrlCrossRefPubMedWeb of Science
  12. ↵
    1. Burtin C,
    2. Saey D,
    3. Langer D,
    4. et al
    . Contractile muscle fatigue is associated with effectiveness of exercise training in COPD. Am J Respir Crit Care Med 2009; 179: A1047.
    OpenUrl
  13. ↵
    1. Rabe KF,
    2. Hurd S,
    3. Anzueto A,
    4. et al
    . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532–555.
    OpenUrlCrossRefPubMedWeb of Science
  14. ↵
    1. Miller MR,
    2. Hankinson J,
    3. Brusasco V,
    4. et al
    . Standardisation of spirometry. Eur Respir J 2005; 26: 319–338.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Wanger J,
    2. Clausen JL,
    3. Coates A,
    4. et al
    . Standardisation of the measurement of lung volumes. Eur Respir J 2005; 26: 511–522.
    OpenUrlAbstract/FREE Full Text
  16. ↵
    1. MacIntyre N,
    2. Crapo RO,
    3. Viegi G,
    4. et al
    . Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005; 26: 720–735.
    OpenUrlAbstract/FREE Full Text
  17. ↵
    1. Rochester DF,
    2. Arora NS
    . Respiratory muscle failure. Med Clin North Am 1983; 67: 573–597.
    OpenUrlPubMedWeb of Science
  18. ↵
    1. Troosters T,
    2. Gosselink R,
    3. Decramer M
    . Six minute walking distance in healthy elderly subjects. Eur Respir J 1999; 14: 270–274.
    OpenUrlAbstract/FREE Full Text
  19. ↵
    1. Jones NL,
    2. Makrides L,
    3. Hitchcock C,
    4. et al
    . Normal standards for an incremental progressive cycle ergometer test. Am Rev Respir Dis 1985; 131: 700–708.
    OpenUrlPubMedWeb of Science
  20. ↵
    1. Guyatt GH,
    2. Berman LB,
    3. Townsend M,
    4. et al
    . A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987; 42: 773–778.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    1. Gosselink HAAM,
    2. Wagenaar RC,
    3. Keimpema VA,
    4. et al
    . The effects of a rehabilitation program in patients with COPD and asthma. Ned Tijdschr Fysioth 1990; 100: 193–199.
    OpenUrl
  22. ↵
    1. Redelmeier DA,
    2. Bayoumi AM,
    3. Goldstein RS,
    4. et al
    . Interpreting small differences in functional status: the six minute walk test in chronic lung disease patients. Am J Respir Crit Care Med 1997; 155: 1278–1282.
    OpenUrlCrossRefPubMedWeb of Science
  23. ↵
    1. Jaeschke R,
    2. Singer J,
    3. Guyatt GH
    . Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989; 10: 407–415.
    OpenUrlCrossRefPubMedWeb of Science
  24. ↵
    1. O'Donnell DE,
    2. Revill SM,
    3. Webb KA
    . Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 770–777.
    OpenUrlCrossRefPubMedWeb of Science
  25. ↵
    1. Saey D,
    2. Michaud A,
    3. Couillard A,
    4. et al
    . Contractile fatigue, muscle morphometry, and blood lactate in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171: 1109–1115.
    OpenUrlCrossRefPubMedWeb of Science
  26. ↵
    1. Saey D,
    2. Lemire BB,
    3. Gagnon P,
    4. et al
    . Quadriceps metabolism during constant workrate cycling exercise in chronic obstructive pulmonary disease. J Appl Physiol 2011; 110: 116–124.
    OpenUrlAbstract/FREE Full Text
  27. ↵
    1. Palange P,
    2. Ward SA,
    3. Carlsen KH,
    4. et al
    . Recommendations on the use of exercise testing in clinical practice. Eur Respir J 2007; 29: 185–209.
    OpenUrlAbstract/FREE Full Text
  28. ↵
    1. Gosselink R,
    2. Troosters T,
    3. Decramer M
    . Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 1996; 153: 976–980.
    OpenUrlCrossRefPubMedWeb of Science
  29. ↵
    1. Langer D,
    2. Hendriks E,
    3. Burtin C,
    4. et al
    . A clinical practice guideline for physiotherapists treating patients with chronic obstructive pulmonary disease based on a systematic review of available evidence. Clin Rehabil 2009; 23: 445–462.
    OpenUrlAbstract/FREE Full Text
  30. ↵
    1. Horowitz MB,
    2. Littenberg B,
    3. Mahler DA
    . Dyspnea ratings for prescribing exercise intensity in patients with COPD. Chest 1996; 109: 1169–1175.
    OpenUrlCrossRefPubMedWeb of Science
  31. ↵
    1. Polkey MI,
    2. Kyroussis D,
    3. Hamnegard CH,
    4. et al
    . Quadriceps strength and fatigue assessed by magnetic stimulation of the femoral nerve in man. Muscle Nerve 1996; 19: 549–555.
    OpenUrlCrossRefPubMedWeb of Science
  32. ↵
    1. Saey D,
    2. Cote CH,
    3. Mador MJ,
    4. et al
    . Assessment of muscle fatigue during exercise in chronic obstructive pulmonary disease. Muscle Nerve 2006; 34: 62–71.
    OpenUrlCrossRefPubMedWeb of Science
  33. ↵
    1. Dolmage TE,
    2. Goldstein RS
    . Effects of one-legged exercise training of patients with COPD. Chest 2008; 133: 370–376.
    OpenUrlCrossRefPubMedWeb of Science
View Abstract
PreviousNext
Back to top
View this article with LENS
Vol 40 Issue 2 Table of Contents
European Respiratory Journal: 40 (2)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Effectiveness of exercise training in patients with COPD: the role of muscle fatigue
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Effectiveness of exercise training in patients with COPD: the role of muscle fatigue
Chris Burtin, Didier Saey, Melda Saglam, Daniel Langer, Rik Gosselink, Wim Janssens, Marc Decramer, François Maltais, Thierry Troosters
European Respiratory Journal Aug 2012, 40 (2) 338-344; DOI: 10.1183/09031936.00111811

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Effectiveness of exercise training in patients with COPD: the role of muscle fatigue
Chris Burtin, Didier Saey, Melda Saglam, Daniel Langer, Rik Gosselink, Wim Janssens, Marc Decramer, François Maltais, Thierry Troosters
European Respiratory Journal Aug 2012, 40 (2) 338-344; DOI: 10.1183/09031936.00111811
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • COPD and smoking
  • Lung structure and function
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Original Article

  • Lung volumes and survival in chronic lung allograft dysfunction
  • Factors associated with FEV1 decline in CF
  • Serum uric acid as a predictor of COPD exacerbations
Show more Original Article

COPD

  • Sensitisation to recombinant A. fumigatus allergens and outcomes in COPD
  • Detection of COPD in the SUMMIT lung cancer screening cohort
  • Flavonoid intakes inversely associate with COPD in smokers
Show more COPD

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society